AHSG and metabolic dysfunction-associated steatotic liver disease: Second, we also found that there was a dose–response relationship between the serum fetuin-A gradient and non-lean NAFLD after adjusting for age, gender, personal habits, WC, and the HOMA-IR (p for trend < 0.05).